<< Back to Results
A multi-center, randomized, double-blind, double-dummy, parallel-group dose-finding study to evaluate the change in HbA1c after 12 weeks monotherapy with seven doses of LIK066 compared with placebo or sitagliptin in patients with type 2 diabetes.
Clinical Trial Categories
- Annette Fudala, RMA, CRC at 215-355-9770
- Feasterville Family Health Care Center N/A
1665 Bustleton Pike
Feasterville, PA 19053